Modeling Progressive Familial Intrahepatic Cholestasis Type I Caused by ATP8B1 deficiency
ATP8B1 缺乏引起的进行性家族性肝内胆汁淤积 I 型建模
基本信息
- 批准号:10722357
- 负责人:
- 金额:$ 16.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:ATP8B1 geneAcidsAdenosineAdoptedAdultAgeAllograftingAnimal ModelAnimalsBile fluidBiochemicalBiological AssayBiological ProcessCRISPR/Cas technologyCell LineCell membraneChildhoodCholestasisChronicComplementCystic Fibrosis Transmembrane Conductance RegulatorDataDevelopmentDiagnosisDiarrheaDiseaseDrug ScreeningDyesEnsureEnterohepatic CirculationEtiologyExcretory functionExhibitsExperimental ModelsExtrahepaticFutureGoalsHealthHepatomegalyHistologicHomeostasisHumanHydrophobicityImageImpairmentIn VitroInterventionIntestinesIntrahepatic CholestasisKnock-outKnowledgeLarvaLifeLipidsLiverMedicalMembraneMembrane FluidityMethodsMissionModelingMusMutationNeonatalOutcomePathogenesisPatient-Focused OutcomesPatientsPharmacologic SubstancePhenotypePhospholipidsProgressive intrahepatic cholestasisProteinsPruritusPublic HealthPumpReceptor SignalingRefractoryResearchResistanceRodent ModelSerumStudy modelsSymptomsTestingUnited States National Institutes of HealthValidationVariantZebrafishanalogautosomebile saltsdisabilitydrug discoveryearly childhoodearly onseteffective therapyend stage liver diseasegraft failurehepatocellular injuryimprovedin vivoin vivo Modelinnovationinsertion/deletion mutationlipid transportliver transplantationmembermutantnew therapeutic targetnovelnovel therapeutic interventionnovel therapeuticspreclinical studyreceptor expressionscreeningsensor
项目摘要
PROJECT SUMMARY/ABSTRACT
ATP8B1/FIC1 belongs to the P4 subfamily of P-type adenosine triphosphatases. In the liver, it is localized
on the bile canalicular membrane to maintain its lipid asymmetry that is essential for proper function of the bile
salt transporters. In humans, mutations in ATP8B1 result in rare forms of chronic intrahepatic cholestasis with
autosomal recessive inheritance. The most severe form of ATP8B1 deficiency, progressive familial intrahepatic
cholestasis type I (PFIC1), is characterized by normal serum GGT cholestasis and pruritus in early childhood
that can progress into end-stage liver disease. Due to the limitations of existing experimental models, ATP8B1
is understudied and our understanding of how ATP8B1 deficiency results in cholestasis remains incomplete,
precluding the development of effective therapy for PFIC1. Our long-term goal is to understand the etiology of
chronic intrahepatic cholestasis and improve patient diagnosis and treatment. The overall objective for this ap-
plication is to establish a novel zebrafish model for ATP8B1 deficiency to better understand the pathogenesis
of cholestasis and discover new therapeutic strategies. Our preliminary study demonstrated that Atp8b1-
deficient zebrafish developed cholestasis and were lethal by 2 weeks of age, providing proof of concept that
zebrafish can be used to model PFIC1. In this application, we propose to conduct further phenotypic analysis
of atp8b1 germline mutant zebrafish and develop assays to study ATP8B1 function in vivo. We will determine
the feasibility of using zebrafish to validate patient variants and test the effect of pharmaceutical intervention on
cholestasis. The rationale is that developing additional animal models of ATP8B1 deficiency will complement
the existing in vitro and rodent models and bring new knowledge into our understanding of ATP8B1 function
and the mechanisms of cholestasis caused by ATP8B1 deficiency. In Aim 1, we will characterize the cholestat-
ic phenotypes caused by Atp8b1 deficiency in zebrafish. We will track the subcellular distribution of fluorescent
lipids in the liver and intestine of wildtype and atp8b1 mutant larvae to understand how ATP8B1 regulates the
transport of lipids in vivo. In Aim 2, we will determine the feasibility of using zebrafish to validate the biological
function of ATP8B1 patient variants. We will introduce two common ATP8B1 missense variants into zebrafish
and determine if they change ATP8B1 expression and cause cholestasis. We will test if treatment with 4-
phenylbutyric acid rescues these animals. The research proposed in this application is highly innovative be-
cause it establishes a novel zebrafish model of ATP8B1 deficiency that offers unique advantages for studying
bile homeostasis and cholestatic phenotypes. We will also develop a pipeline for future drug screen to identify
compounds that rescue cholestasis caused by ATP8B1 deficiency. The study is also significant because this
new in vivo model is expected to advance our understanding of ATP8B1 function in bile homeostasis and
pathogenesis of PFIC1. The results from the study will provide critical preliminary data for a highly competitive
R01 application to further pursue disease mechanisms and drug discovery.
项目总结/摘要
ATP 8B 1/FIC 1属于P型腺苷三磷酸酶的P4亚家族。在肝脏,它是局部的
以维持其脂质不对称性,这对胆汁的正常功能至关重要
盐运输者。在人类中,ATP 8B 1突变导致罕见形式的慢性肝内胆汁淤积,
常染色体隐性遗传ATP 8B 1缺陷的最严重形式,进行性家族性肝内
胆汁淤积症I型(PFIC 1)的特征是儿童早期的正常血清GGT胆汁淤积和瘙痒
会发展成终末期肝病由于现有实验模型的局限性,
我们对ATP 8B 1缺乏如何导致胆汁淤积的理解仍然不完整,
从而阻碍了对PFIC 1的有效治疗的发展。我们的长期目标是了解
提高慢性肝内胆汁淤积症的诊断和治疗水平。本项目的总体目标是--
目的是建立一种新的ATP 8B 1缺乏症斑马鱼模型,以更好地了解其发病机制
并发现新的治疗策略。我们的初步研究表明Atp 8b 1-
缺陷型斑马鱼发展为胆汁淤积,并且在2周龄时是致命的,这提供了概念上的证据,
斑马鱼可用于模拟PFIC 1。在本申请中,我们建议进行进一步的表型分析
的atp 8b 1种系突变斑马鱼,并开发测定研究ATP 8B 1在体内的功能。我们将确定
使用斑马鱼验证患者变异的可行性,并测试药物干预对
胆汁淤积其基本原理是,开发额外的ATP 8B 1缺陷动物模型将补充
现有的体外和啮齿动物模型,并为我们理解ATP 8B 1功能带来新的知识
以及ATP 8B 1缺乏引起胆汁淤积的机制。在目标1中,我们将表征胆固醇-
斑马鱼Atp 8b 1缺陷引起的ic表型我们将跟踪荧光蛋白的亚细胞分布,
野生型和atp 8b 1突变体幼虫肝脏和肠道中的脂质,以了解ATP 8B 1如何调节
脂质在体内的转运。在目标2中,我们将确定使用斑马鱼验证生物学的可行性。
ATP 8B 1患者变体的功能。我们将在斑马鱼中引入两种常见的ATP 8B 1错义变体
并确定它们是否改变ATP 8B 1表达并引起胆汁淤积。我们将测试是否用4-
苯丁酸拯救了这些动物本申请中提出的研究具有很高的创新性-
因为它建立了一种新的ATP 8B 1缺陷的斑马鱼模型,为研究提供了独特的优势
胆汁稳态和胆汁淤积表型。我们还将为未来的药物筛选开发一个管道,
这些化合物可以拯救由ATP 8B 1缺乏引起的胆汁淤积。这项研究也很重要,因为
一种新的体内模型有望促进我们对ATP 8B 1在胆汁稳态中功能的理解,
PFIC的发病机制1.该研究的结果将为竞争激烈的
R 01的应用,以进一步追求疾病机制和药物发现。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chunyue Yin其他文献
Chunyue Yin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chunyue Yin', 18)}}的其他基金
Molecular targets in cholestasis caused by bile salt export pump deficiency
胆盐输出泵缺陷引起的胆汁淤积的分子靶点
- 批准号:
10456780 - 财政年份:2018
- 资助金额:
$ 16.05万 - 项目类别:
Molecular targets in cholestasis caused by bile salt export pump deficiency
胆盐输出泵缺陷引起的胆汁淤积的分子靶点
- 批准号:
9789255 - 财政年份:2018
- 资助金额:
$ 16.05万 - 项目类别:
Regulation of hepatic stellate cells in development and alcoholic liver injury
肝星状细胞发育和酒精性肝损伤的调控
- 批准号:
8788863 - 财政年份:2014
- 资助金额:
$ 16.05万 - 项目类别:
Regulation of hepatic stellate cells in development and alcoholic liver injury
肝星状细胞发育和酒精性肝损伤的调控
- 批准号:
9015723 - 财政年份:2014
- 资助金额:
$ 16.05万 - 项目类别:
Regulation of hepatic stellate cells in development and alcoholic liver injury
肝星状细胞发育和酒精性肝损伤的调控
- 批准号:
8164707 - 财政年份:2011
- 资助金额:
$ 16.05万 - 项目类别:
Regulation of hepatic stellate cells in development and alcoholic liver injury
肝星状细胞发育和酒精性肝损伤的调控
- 批准号:
8580763 - 财政年份:2011
- 资助金额:
$ 16.05万 - 项目类别:
相似国自然基金
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
- 批准号:22007039
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
- 批准号:
- 批准年份:2019
- 资助金额:10.0 万元
- 项目类别:省市级项目
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
- 批准号:21372217
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
- 批准号:21172061
- 批准年份:2011
- 资助金额:30.0 万元
- 项目类别:面上项目
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
- 批准号:21176225
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
- 批准号:81072511
- 批准年份:2010
- 资助金额:31.0 万元
- 项目类别:面上项目
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
- 批准号:30660215
- 批准年份:2006
- 资助金额:21.0 万元
- 项目类别:地区科学基金项目
相似海外基金
CAREER: Highly Rapid and Sensitive Nanomechanoelectrical Detection of Nucleic Acids
职业:高度快速、灵敏的核酸纳米机电检测
- 批准号:
2338857 - 财政年份:2024
- 资助金额:
$ 16.05万 - 项目类别:
Continuing Grant
Lipid nanoparticle-mediated Inhalation delivery of anti-viral nucleic acids
脂质纳米颗粒介导的抗病毒核酸的吸入递送
- 批准号:
502577 - 财政年份:2024
- 资助金额:
$ 16.05万 - 项目类别:
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 16.05万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 16.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
- 批准号:
2300890 - 财政年份:2023
- 资助金额:
$ 16.05万 - 项目类别:
Continuing Grant
Integrated understanding and manipulation of hypoxic cellular functions by artificial nucleic acids with hypoxia-accumulating properties
具有缺氧累积特性的人工核酸对缺氧细胞功能的综合理解和操纵
- 批准号:
23H02086 - 财政年份:2023
- 资助金额:
$ 16.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 16.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 16.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 16.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Synthetic analogues based on metabolites of omega-3 fatty acids protect mitochondria in aging hearts
基于 omega-3 脂肪酸代谢物的合成类似物可保护衰老心脏中的线粒体
- 批准号:
477891 - 财政年份:2023
- 资助金额:
$ 16.05万 - 项目类别:
Operating Grants